Press release
European Medicines Agency and European Food Safety Authority commit to a stronger collaboration
February 9, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
The European Medicines Agency (EMA) and the European Food Safety Authority (EFSA) have agreed to work closer together on areas …
Catalent expands controlled release drug development and supply capabilities at its Schorndorf, Germany Facility
January 31, 2012Manufacturing and Production
Somerset, NJ –January 25, 2012 — Catalent Pharma Solutions continues to expand its drug development and delivery capabilities to help …
Catalent acquires current minority interest in R.P. Scherer, Eberbach, Germany
January 31, 2012Manufacturing and Production
SOMERSET, NJ, January 30, 2012 – Catalent Pharma Solutions, a leading global drug delivery technology company, today announced the signing …
Medical Research Network starts major global expansion programme
January 27, 2012Business Services
Leading unique Clinical Trial Support Organisation (CTSO), Medical Research Network (MRN), has completed the first stage of a major global …
New Leg-Mounted Autoclaves for Designated Clean-rooms
January 26, 2012Manufacturing and Production
Availability of stand-off legs for Priorclave’s range of bench-top autoclaves brings significant advantages to designated CAT 3 application areas providing …
MHRA Inspections of CROs
January 24, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Audits, Wainwright Associates, inspectons
In accordance with the provisions of the new pharmacovigilance legislation, as per Directive 2010/84/EU, EU Competent Authorities may inspect the …
Payment changes of authority’s fees in France
January 20, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates, regulatory affairs
Changes are being made in the way fees are paid for regulatory submissions and procedures in France. Fees are no …
CoreLab Partners opens office in Tokyo, Japan
January 17, 2012Research and Development
Princeton, NJ January 17, 2012 – Signaling a further commitment to expand its business model in the Pacific Rim and …
New requirements for the technical validations of Marketing Authorisation Applications
January 6, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
The current EU- eCTD v3.1 validation criteria came into force on 1st September 2011 for the technical validation for all …
Priorclave Success at London Vet show
December 19, 2011Manufacturing and Production
During the recent London Vet Show the autoclave featured on the Southwest Medical stand R30 certainly proved a popular visitor …
University Teaching Labs Buy into Priorclaves for Better Performance
December 19, 2011Manufacturing and Production
York University is shortly taking delivery of a number of priorclaves for use in the Biology Department’s Teaching Laboratories and …
Dechra Pharmaceuticals PLC FDA Approval for manufacturing at Dales Pharmaceuticals
December 9, 2011Manufacturing and Production, Research and Development FDA Approval
Dechra® Pharmaceuticals PLCFDA APPROVAL FOR MANUFACTURING AT DALES® PHARMACEUTICALS Dales Pharmaceuticals (‘Dales’ or the ‘Company’), based in Skipton, North Yorkshire, UK, …
New EU Cosmetics Regulation
December 7, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
The European Cosmetics Directive has been recast and the new legislation takes the form of Regulation 1223/2009. As a Regulation, …
Catalent Announces plans to increase Biologic Development and Manufacturing Capabilities
December 7, 2011Manufacturing and Production
SOMERSET, NJ, December 7, 2011 — Catalent Pharma Solutions, a leading provider of drug and biologic development services, delivery technologies …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
